DexCom Inc.
Last updated September 27, 2026
Organization details
- Legal name
- DexCom Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DXCM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001093557
- EIN
- 33-0857544
Board of directors
-
Albert Frederick Osterloh IV · DirectorSince 2026
-
Barbara Kahn · DirectorSince 2023
-
Bridgette P. Heller · DirectorSince 2023
-
Eric Topol · DirectorSince 2023
-
Euan A. Ashley · DirectorSince 2025
-
Glenn S. Boehnlein · DirectorSince 2026
-
Jacob Steven Leach · Director · President, CEO, and DirectorSince 2026
-
Jay S. Skyler · DirectorSince 2023
-
Karen M. Dahut · DirectorSince 2023
-
Kevin R. Sayer · Director · Executive ChairSince 2023
-
Kyle Malady · DirectorSince 2023
-
Mark G. Foletta · DirectorSince 2023
-
Nicholas Augustinos · DirectorSince 2023
-
Renee D. Gala · DirectorSince 2025
-
Richard Alexander Collins · DirectorSince 2023
-
Rimma Driscoll · DirectorSince 2023
-
Steven R. Altman · DirectorSince 2023
Chief executives
Kevin R. Sayer
· President CEO and Chairman
Dates unknown
Jacob Steven Leach
· President, CEO, and Director
Dates unknown
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.7%
-
94.5%
-
95.1%
-
96.0%
-
97.8%
-
98.2%
-
98.5%
-
99.3%
-
99.7%
-
99.7%
-
99.8%
Board connections
6 of this board's directors also sit on 8 other boards.
- via Mark G. Foletta
- via Glenn S. Boehnlein
- via Bridgette P. Heller
- via Mark G. Foletta
- via Renee D. Gala
- via Glenn S. Boehnlein
- via Jay S. Skyler
- via Jacob Steven Leach
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,001,761
- 2 purchases by 1 insider
- Sold, last 12 months
- $12,402,948
- 29 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Brown Michael Jon Officer (EVP Chief Legal Compliance Off) | Open-market sale | −1,700 | $84.04 | $142,868 |
| Sep 15, 2026 | Nicholas Augustinos Director | Open-market sale | −6,539 | $84.04 | $549,538 |
| Sep 14, 2026 | Nicholas Augustinos Director | Open-market sale | −1,550 | $84.02 | $130,231 |
| Sep 10, 2026 | Glenn S. Boehnlein Director | Grant or award | +5,841 | — | — |
| Sep 10, 2026 | Sylvain Jereme M Officer (EVP, Chief Financal Officer) | Open-market sale | −3,638 | $83.27 | $302,936 |
| Aug 27, 2026 | Stern Sadie Officer (EVP Chief People & Culture Off) | Open-market sale | −2,565 | $88.37 | $226,669 |
| Aug 22, 2026 | Brown Michael Jon Officer (EVP Chief Legal Compliance Off) | Shares withheld for tax | −1,451 | $92.34 | $133,985 |
| Aug 22, 2026 | Stern Sadie Officer (EVP Chief People & Culture Off) | Shares withheld for tax | −1,451 | $92.34 | $133,985 |
| Aug 22, 2026 | Sylvain Jereme M Officer (EVP, Chief Financal Officer) | Shares withheld for tax | −1,451 | $92.34 | $133,985 |
| Aug 22, 2026 | Jacob Steven Leach Director, Officer (President, CEO, and Director) | Shares withheld for tax | −1,451 | $92.34 | $133,985 |
| Aug 20, 2026 | Kevin R. Sayer Director, Officer (Executive Chair) | Open-market sale | −19,308 | $89.71 | $1,732,043 |
| Aug 20, 2026 | Kevin R. Sayer Director, Officer (Executive Chair) | Open-market sale | −7,351 | $90.78 | $667,332 |
| Aug 20, 2026 | Kevin R. Sayer Director, Officer (Executive Chair) | Open-market sale | −97 | $91.41 | $8,867 |
| Aug 14, 2026 | Brown Michael Jon Officer (EVP Chief Legal Compliance Off) | Open-market sale | −1,700 | $91.93 | $156,281 |
| Aug 12, 2026 | Nicholas Augustinos Director | Gift | −1,075 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.